DTIL — PRECISION BIOSCIENCES INC
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1357874 ·
Last close
$7.58
Market Cap
$195.58M
52W High
$8.59
52W Low
$3.96
ADV30
222,860
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 10,838,000 | — | -9,075,000 | -18,441,000 | 143,891,000 | 99,370,000 | 67,790,000 |
| Dec 2025 | 34,204,000 | — | 12,508,000 | 20,133,000 | 154,416,000 | 110,823,000 | 62,168,000 |
| Sep 2025 | 13,000 | — | -20,667,000 | -21,772,000 | 93,510,000 | 44,870,000 | 76,876,000 |
| Jun 2025 | 18,000 | — | -21,877,000 | -23,520,000 | 108,928,000 | 62,242,000 | 74,874,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-65,843,000
Investing CF
$-634,000
Financing CF
$95,162,000
CapEx
$-797,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-5.13
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-528,188,000
Inventory
—
Receivables
$0
ST Investments
$4,762,000
EBIT TTM
$-45,187,000
Pretax Income TTM
$-46,609,000
Interest Exp TTM
$1,422,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$45,073,000
EBITDA
$-37,739,000
Free Cash Flow
$-21,668,250
Enterprise Value
$113,832,248
Total Cash
$101,184,000
Total Debt
$28,466,000
Shares Out
25,802,247
Trailing EPS
$-2.17
Book Value
$3.83
ROE
-70.9%
ROA
-18.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 34,264,000 | -52,148,000 | -45,724,000 | 154,416,000 | 62,168,000 | — | -65,843,000 |
| Dec 2024 | 68,696,000 | -26,162,000 | 7,167,000 | 136,388,000 | 79,995,000 | — | -58,445,000 |
| Dec 2023 | 48,727,000 | -43,736,000 | -61,319,000 | 159,781,000 | 140,920,000 | — | -84,114,000 |
| Dec 2022 | 25,098,000 | -62,308,000 | -111,637,000 | 238,169,000 | 177,736,000 | — | -45,753,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.92
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IPHYF | Innate Pharma SA | $211.28M | $2.25 | — |
| CRBU | Caribou Biosciences, Inc. | $214.23M | $2.16 | — |
| ABOS | Acumen Pharmaceuticals, Inc. | $174.79M | $2.42 | — |
| PLX | Protalix BioTherapeutics, Inc. | $172.42M | $2.14 | — |
| IKT | Inhibikase Therapeutics, Inc. | $224.46M | $1.70 | — |
News headlines (Yahoo Finance, 1h cache)
[Latest] Global Genome Editing Market Size/Share Worth USD 55.7 Billion by 2035 at a 17.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate,
2026-05-21 17:30 · Yahoo
Precision BioSciences to Host Investor Webcast to Discuss Late-Breaking PBGENE-HBV Data from ELIMINATE-B Trial Presented at European Association for the Study of the Liver Congress 2026
2026-05-21 11:01 · Yahoo
Precision BioSciences Presents New Preclinical Data Supporting the Advancement of PBGENE-DMD into Clinic at the American Society of Gene & Cell Therapy 2026 Annual Meeting
2026-05-14 11:01 · Yahoo
Bullish: Analysts Just Made A Notable Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts
2026-05-13 11:07 · Yahoo
Precision BioSciences (DTIL) Reports Q1 Loss, Tops Revenue Estimates
2026-05-05 12:25 · Yahoo
Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update
2026-05-05 11:01 · Yahoo
Precision BioSciences to Report First Quarter 2026 Financial Results on May 5, 2026
2026-04-30 11:01 · Yahoo
Precision BioSciences Activates First Clinical Trial Site and Begins Patient Enrollment in Phase 1/2 FUNCTION-DMD Study
2026-04-29 11:01 · Yahoo
Precision BioSciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting
2026-04-28 11:01 · Yahoo
AnaptysBio (ANAB) Surges 14.8%: Is This an Indication of Further Gains?
2026-04-27 12:18 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.